ArticlemedRxiv : the preprint server for health sciences2022

Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.

Jennifer Sasson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.